ERGIC2 anticorps (C-Term)
-
- Antigène Voir toutes ERGIC2 Anticorps
- ERGIC2 (ERGIC and Golgi 2 (ERGIC2))
-
Épitope
- AA 334-362, C-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp ERGIC2 est non-conjugé
-
Application
- Western Blotting (WB), Enzyme Immunoassay (EIA)
- Specificité
- This antibody recognizes Human ERGIC2 (C-term).
- Purification
- Affinity Chromatography on Protein A
- Immunogène
- KLH conjugated synthetic peptide between 334-362 amino acids from the C-terminal region of Human ERGIC2
- Isotype
- Ig Fraction
- Top Product
- Discover our top product ERGIC2 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.25 mg/mL
- Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freezing and thawing.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- Antigène
- ERGIC2 (ERGIC and Golgi 2 (ERGIC2))
- Autre désignation
- ERGIC2 (ERGIC2 Produits)
- Synonymes
- anticorps ptx1, anticorps MGC75899, anticorps zgc:64005, anticorps Erv41, anticorps PTX1, anticorps cd002, anticorps 1200009B18Rik, anticorps 4930572C01Rik, anticorps AA408438, anticorps Ptx1, anticorps RGD1310606, anticorps ERGIC and golgi 2, anticorps ERGIC and golgi 2 S homeolog, anticorps ergic2, anticorps ERGIC2, anticorps ergic2.S, anticorps Ergic2
- Sujet
- ERGIC2, or PTX1, is a ubiquitously expressed nuclear protein that is downregulated in prostate carcinoma (Kwok et al., 2001 [PubMed 11445006]).Synonyms: CDA14, ERV41, Endoplasmic reticulum-Golgi intermediate compartment protein 2, PTX1
- Poids moléculaire
- 42549 Da
- ID gène
- 51290
- NCBI Accession
- NP_057654
-